Your January Issue: 3 Steps to Healthier Skin
Happy New Year! We hope that keeping your skin safe and healthy is one of your goals for 2025. Here are three easy ways to get started:
Happy New Year! We hope that keeping your skin safe and healthy is one of your goals for 2025. Here are three easy ways to get started:
OST-HER2 led to significant 12-month event-free survival and demonstrated favorable overall survival trends at 1 and 2 years in recurrent, fully resected osteosarcoma and lung…
Optimizing Treatment Strategies for Localized and Advanced Genitourinary MalignanciesPresented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education.
PHILADELPHIA (January 21, 2025) — Yash Chhabra, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently…
Dr. Aditya Bardia presents real-world findings on elacestrant, demonstrating prolonged real-world progression-free survival (rwPFS) in ER+/HER2- advanced breast cancer patients across all clinically relevant subgroups,…
Standardizing surgical outcomes and better training oncologic surgeons may be accomplished through the use of AI.
Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.These individuals likely would benefit from…
A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that microscopic worms exposed to frigid…
Leonidas Platanias, MD, PhD Director, Lurie Cancer Center In 2024, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University continued to advance our understanding…
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
This clinical insights article is derived from recommendations in Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. This document is based on…